Science Explorer Back to mapMap
Discussion
Company · Shenzhen · ??

Shenzhen Chipscreen Biosciences Co.

chipscreen.comROR OpenAlex
Research works
21
▼ 30% vs 2018-21
Citations
581
27.9 per fractional work
Top-10% rate
17.8%
all institutions 10.0%
Open access
47%
world 40%
International
8%
world 18%
Shenzhen Chipscreen Biosciences Co.

Not ranked overall: Shenzhen Chipscreen Biosciences Co. is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Shenzhen Chipscreen Biosciences Co. work in?

In all years, 55% of research at Shenzhen Chipscreen Biosciences Co. is in Life Sciences, 42% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (46%), Medicine (42%), Pharmacology, Toxicology and Pharmaceutics (5%). It does 2.3× the world's share of Life Sciences.

Life Sciences: 11 fractional works · 54.6% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 45.8% of its workMolecular Biology: 9 fractional works · 41.9% of its workCancer Research: 0 fractional works · 1.2% of its workCell Biology: 0 fractional works · 0.8% of its workBiotechnology: 0 fractional works · 0.7% of its workBiochemistry: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 4.5% of its workPharmacology: 1 fractional works · 3.7% of its workPharmaceutical Science: 0 fractional works · 0.8% of its workImmunology and Microbiology: 0 fractional works · 2.4% of its workImmunology: 0 fractional works · 2.4% of its workNeuroscience: 0 fractional works · 1.1% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.8% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.8% of its workHealth Sciences: 9 fractional works · 41.8% of its workMedicine: 9 fractional works · 41.8% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 9.2% of its workOncology: 2 fractional works · 8.0% of its workPhysiology: 1 fractional works · 6.3% of its workComplementary and alternative medicine: 1 fractional works · 3.7% of its workRheumatology: 1 fractional works · 3.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.1% of its workEpidemiology: 1 fractional works · 2.9% of its workPathology and Forensic Medicine: 0 fractional works · 1.7% of its workHematology: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workDermatology: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.5% of its workSurgery: 0 fractional works · 0.4% of its workPhysical Sciences: 1 fractional works · 2.8% of its workChemistry: 0 fractional works · 2.3% of its workAnalytical Chemistry: 0 fractional works · 1.6% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workComputer Science: 0 fractional works · 0.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 0.8% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.8% of its workEconomics and Econometrics: 0 fractional works · 0.8% of its workALL ITS WORKShenzhenChipscreen…21fractional works, all years
Life Sciences55%Physical Sciences3%Health Sciences42%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1045.8%
    2. Pharmacology, Toxicology and Pharmaceutics14.5%
    3. Immunology and Microbiology02.4%
    4. Neuroscience01.1%
    5. Agricultural and Biological Sciences00.8%
    1. Medicine941.8%
    1. Chemistry02.3%
    2. Computer Science00.5%
    1. Economics, Econometrics and Finance00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.51× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.57× its world share, 0 worksImmunology and Micro…Neuroscience: 2.83× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.79× its world share, 0 worksPharmacology, Toxico…Medicine: 2.56× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 1.61× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.8×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics9.79×0 works
  2. Biochemistry, Genetics and Molecular Biology6.51×2 works
  3. Immunology and Microbiology4.57×0 works
  4. Neuroscience2.83×0 works
  5. Medicine2.56×2 works
  6. Economics, Econometrics and Finance1.61×0 works

Who are the top researchers at Shenzhen Chipscreen Biosciences Co.?

Ranked on the quality score, Xianping Lu, Zhiqiang Ning and Desi Pan lead among researchers whose main affiliation is Shenzhen Chipscreen Biosciences Co..

  1. 1 Xianping Lu #701,019 worldwide 2.9k citations · 70 works
  2. 2 Zhiqiang Ning #1,043,354 worldwide 2.4k citations · 54 works
  3. 3 Desi Pan #1,892,746 worldwide 1.4k citations · 53 works
All ranked researchers at Shenzhen Chipscreen Biosciences Co.

What are the most cited papers from Shenzhen Chipscreen Biosciences Co.?

The most cited paper from Shenzhen Chipscreen Biosciences Co. is "Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma" (Yue Shi, Mei Dong, Xiaoting Hong et al., 2015), with 407 citations. Next come "Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity" (301) and "Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial" (273).

Most cited papers
#PaperReleasedCitations
1 Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma Yue Shi, Mei Dong, Xiaoting Hong et al. · Annals of Oncology Open access 23 Jun 2015 407
2 Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity Zhiqiang Ning, Zhibin Li, Michael J. Newman et al. · Cancer Chemotherapy and Pharmacology 11 Nov 2011 301
3 Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial Zefei Jiang et al. · The Lancet Oncology 27 Apr 2019 273
4 Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China Xianping Lu, Zhiqiang Ning, Zhibin Li et al. · Intractable & Rare Diseases Research Open access 2016 169
5 Advances in targeting histone deacetylase for treatment of solid tumors Mu-Qi Shi, Ying Xu, Xin Fu et al. · Journal of Hematology & Oncology Open access 31 May 2024 158
All 56 most cited papers, with filters and sorting

Which keywords describe research at Shenzhen Chipscreen Biosciences Co.?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Transcriptional Regulation, Cancer Therapy, Metabolism, Cancer, Insulin Resistance, Diabetes and Obesity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Inflammation4▲ 8.9×10 topics
  2. Transcriptional Regulation3▲ 62×4 topics
  3. Cancer Therapy3▲ 24×7 topics
  4. Metabolism3▲ 21×8 topics
  5. Cancer3▲ 9.2×9 topics
  6. Insulin Resistance3▲ 28×5 topics
  7. Diabetes2▲ 24×3 topics
  8. Obesity2▲ 15×5 topics
  9. Epigenetic Regulation2▲ 51×4 topics
  10. Gene Expression2▲ 16×3 topics
  11. HDAC Inhibitors2▲ 498×1 topic
  12. Histone Deacetylases2▲ 498×1 topic
  13. Nuclear Receptors2▲ 51×2 topics
  14. PPARs2▲ 271×1 topic
  15. Peroxisome Proliferator-Activated Receptors2▲ 271×1 topic
  16. Tumor Microenvironment2▲ 21×5 topics
  17. Brown Adipose Tissue1▲ 86×1 topic
  18. Thermogenesis1▲ 86×1 topic
  19. BET Bromodomains1▲ 274×1 topic
  20. PROTACs1▲ 274×1 topic
  21. VEGF1▲ 162×1 topic
  22. endothelial progenitor cells1▲ 162×1 topic
  23. Herbal Medicine1▲ 23×2 topics
  24. Type 2 Diabetes1▲ 28×3 topics
  25. Bioactive Compounds1▲ 25×2 topics

Which research topics does Shenzhen Chipscreen Biosciences Co. publish most on?

By volume in 2022-now: Thyroid Disorders and Treatments, Liver Disease Diagnosis and Treatment, Growth Hormone and Insulin-like Growth Factors and Phosphodiesterase function and regulation.

Thyroid Disorders and Tr…0Thyroid Disorders and Treatments: 0 fractional worksLiver Disease Diagnosis …0Liver Disease Diagnosis and Treatment: 0 fractional worksGrowth Hormone and Insul…0Growth Hormone and Insulin-like Growth Factors: 0 fractional worksPhosphodiesterase functi…0Phosphodiesterase function and regulation: 0 fractional worksChemical Reactions and Isotopes: 0 fractional worksCancer-related gene regulation: 0 fractional worksDiabetes, Cardiovascular…0Diabetes, Cardiovascular Risks, and Lipoproteins: 0 fractional worksPeroxisome Proliferator-Activated Receptors: 0 fractional worksDiabetes Treatment and Management: 0 fractional worksPharmaceutical Economics…0Pharmaceutical Economics and Policy: 0 fractional works
Endocrinology, Diabetes and MetabolismEpidemiologyMolecular BiologyPharmaceutical Science1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Thyroid Disorders and Treatments Endocrinology, Diabetes and Metabolism 0 works
  2. 2 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  3. 3 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 0 works
  4. 4 Phosphodiesterase function and regulation Molecular Biology 0 works
  5. 5 Chemical Reactions and Isotopes Pharmaceutical Science 0 works
  6. 6 Cancer-related gene regulation Molecular Biology 0 works
  7. 7 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Peroxisome Proliferator-Activated Receptors Molecular Biology 0 works
  9. 9 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  10. 10 Pharmaceutical Economics and Policy Economics and Econometrics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.6%not open53.4%

World: 40% of research is openly available.

with international co-authors8.0%domestic only92.0%

World: 18% is written across borders.

How has Shenzhen Chipscreen Biosciences Co.'s research output changed?

Output in 2022-2025 was 30% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Shenzhen Chipscreen Biosciences Co. as a percentage of every work published that year, 0.000032% in 2023.

0.000050%0.00010%Shenzhen Chipscreen Biosciences Co.0.000027% in 202420102020

Fractional works of Shenzhen Chipscreen Biosciences Co. over all fractional works that year. How the balance of science has shifted.

Other research institutions in Shenzhen

All research institutions in Shenzhen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Shenzhen Chipscreen Biosciences Co.. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.